For research use only. Not for therapeutic Use.
Dabigatran Etexilate-d13 is an isotopically labeled form of dabigatran etexilate, featuring thirteen deuterium atoms. This compound is particularly valuable in pharmaceutical research, especially in the study of the pharmacokinetics, metabolism, and bioavailability of dabigatran, a widely used anticoagulant. The deuterium labeling enhances the precision and sensitivity of mass spectrometric analyses, allowing researchers to accurately track and quantify the compound in biological systems. Dabigatran Etexilate-d13 is crucial for investigating the metabolic pathways, drug interactions, and therapeutic monitoring of dabigatran. Its high purity and stability make it an indispensable tool in advanced drug development and clinical research, providing reliable data for optimizing anticoagulant therapies
| Catalog Number | R065793 |
| CAS Number | 2749293-92-1 |
| Synonyms | ethyl 3-(2-(((4-(N-(((hexyl-d13)oxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
| Molecular Formula | C24H28D13N7O5 |
| Purity | ≥95% |
| Storage | -20°C |
| IUPAC Name | ethyl 3-[[1-methyl-2-[[4-[N-(1,1,2,2,3,3,4,4,5,5,6,6,6-tridecadeuteriohexoxycarbonyl)carbamimidoyl]anilino]methyl]benzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate |
| InChI | InChI=1S/C34H41N7O5/c1-4-6-7-10-21-46-34(44)39-32(35)24-12-15-26(16-13-24)37-23-30-38-27-22-25(14-17-28(27)40(30)3)33(43)41(20-18-31(42)45-5-2)29-11-8-9-19-36-29/h8-9,11-17,19,22,37H,4-7,10,18,20-21,23H2,1-3H3,(H2,35,39,44)/i1D3,4D2,6D2,7D2,10D2,21D2 |
| InChIKey | KSGXQBZTULBEEQ-BTQQZDERSA-N |
| SMILES | [2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])OC(=O)NC(=N)C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4 |
